glp-1 agonists A Closer Look at the Dermatological Profile of GLP1 Receptor Agonists—Effects beyond Obesity

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

2023 2 Minute Medicine, Inc

Ozempic alternatives in the GLP-1 family offer effective weight loss pathways

Brand: Pendulum

We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity

The oral version must be taken in a special way - it should be taken after fasting overnight, with a small amount of water (no more than half a cup)